UK Medical Device Technology Market 2026-2035
Description
UK Medical Device Technology Market Size, Share & Trends Analysis Report by Device Type (In Vitro Diagnostics Devices, Diagnostic Imaging Devices, Cardiology Devices, Ophthalmology Devices, Orthopedic Devices, and Others) Forecast Period 2026-2035
Industry Overview
UK medical device technology market was valued at $19.9 billion in 2025 and is projected to reach $31.3 billion by 2035, growing at a CAGR of 4.7% during the forecast period (2026–2035). The UK medical device technology market is experiencing steady growth, driven by the modernization of healthcare infrastructure, rising demand for advanced diagnostic and therapeutic solutions, and the increasing prevalence of chronic diseases. Hospitals and specialty centers are investing in high-precision imaging systems, automated laboratory equipment, and minimally invasive devices to enhance patient outcomes. Government initiatives supporting innovation, faster regulatory approvals, and the adoption of digital health technologies are further accelerating market expansion. Collaborations between domestic and international manufacturers are enabling the introduction of next-generation devices across various clinical settings.
Market Dynamics
Focus on Digital Diagnostics
The UK is seeing strong adoption of digital diagnostic solutions, including AI-assisted imaging, automated laboratory analyzers, and point-of-care testing platforms. This is driven by the need for faster and more accurate disease detection and management. Key players such as Roche, Abbott, and Siemens Healthineers are expanding their offerings with advanced, integrated diagnostic tools. Recent trends highlight increased integration of cloud-based reporting and remote monitoring to streamline clinical workflows and improve patient care.
Growth in Minimally Invasive and Specialty Devices
Minimally invasive devices are gaining traction in cardiology, orthopedics, and ophthalmology as healthcare providers prioritize reduced recovery times and improved procedural outcomes. Hospitals are adopting robotic-assisted systems, image-guided tools, and precision implants to support complex procedures. Leading companies, including Medtronic, Boston Scientific, and Stryker, are introducing scalable and efficient solutions suitable for UK healthcare settings. Recent developments also include partnerships between manufacturers and NHS facilities to optimize device performance and accessibility.
Market Segmentation
The IVD segment in the UK is expanding due to higher demand for automated laboratory systems, molecular testing platforms, and point-of-care solutions. Rising chronic disease prevalence, aging population, and government support for laboratory modernization are driving growth. Companies such as Roche, Abbott, and Siemens Healthineers are introducing innovative solutions that improve speed, accuracy, and workflow efficiency. Digital integration and AI-based interpretation are increasingly being adopted to enhance diagnostic decision-making.
Diagnostic Imaging Devices: A Key Segment in Market Growth
Diagnostic imaging remains a key growth area in the UK, supported by investments in advanced MRI, CT, ultrasound, and digital X-ray systems. Hospitals and specialty centers are upgrading equipment to ensure precise diagnostics and faster results. The prominent market players, including GE HealthCare, Philips, and Canon Medical, are offering energy-efficient, compact, and AI-enhanced imaging solutions. Cloud-based storage, remote reading, and AI-assisted analysis are increasingly used to optimize workflow and diagnostic accuracy.
Market Players Outlook
The major companies operating in the UK medical device technology market include Medtronic plc, Siemens Healthineers, GE Healthcare, Abbott Laboratories, and B. Braun Melsungen SE, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
Industry Overview
UK medical device technology market was valued at $19.9 billion in 2025 and is projected to reach $31.3 billion by 2035, growing at a CAGR of 4.7% during the forecast period (2026–2035). The UK medical device technology market is experiencing steady growth, driven by the modernization of healthcare infrastructure, rising demand for advanced diagnostic and therapeutic solutions, and the increasing prevalence of chronic diseases. Hospitals and specialty centers are investing in high-precision imaging systems, automated laboratory equipment, and minimally invasive devices to enhance patient outcomes. Government initiatives supporting innovation, faster regulatory approvals, and the adoption of digital health technologies are further accelerating market expansion. Collaborations between domestic and international manufacturers are enabling the introduction of next-generation devices across various clinical settings.
Market Dynamics
Focus on Digital Diagnostics
The UK is seeing strong adoption of digital diagnostic solutions, including AI-assisted imaging, automated laboratory analyzers, and point-of-care testing platforms. This is driven by the need for faster and more accurate disease detection and management. Key players such as Roche, Abbott, and Siemens Healthineers are expanding their offerings with advanced, integrated diagnostic tools. Recent trends highlight increased integration of cloud-based reporting and remote monitoring to streamline clinical workflows and improve patient care.
Growth in Minimally Invasive and Specialty Devices
Minimally invasive devices are gaining traction in cardiology, orthopedics, and ophthalmology as healthcare providers prioritize reduced recovery times and improved procedural outcomes. Hospitals are adopting robotic-assisted systems, image-guided tools, and precision implants to support complex procedures. Leading companies, including Medtronic, Boston Scientific, and Stryker, are introducing scalable and efficient solutions suitable for UK healthcare settings. Recent developments also include partnerships between manufacturers and NHS facilities to optimize device performance and accessibility.
Market Segmentation
- Based on the device type, the market is segmented into in vitro diagnostics devices, diagnostic imaging devices, cardiology devices, ophthalmology devices, orthopedic devices, and others.
The IVD segment in the UK is expanding due to higher demand for automated laboratory systems, molecular testing platforms, and point-of-care solutions. Rising chronic disease prevalence, aging population, and government support for laboratory modernization are driving growth. Companies such as Roche, Abbott, and Siemens Healthineers are introducing innovative solutions that improve speed, accuracy, and workflow efficiency. Digital integration and AI-based interpretation are increasingly being adopted to enhance diagnostic decision-making.
Diagnostic Imaging Devices: A Key Segment in Market Growth
Diagnostic imaging remains a key growth area in the UK, supported by investments in advanced MRI, CT, ultrasound, and digital X-ray systems. Hospitals and specialty centers are upgrading equipment to ensure precise diagnostics and faster results. The prominent market players, including GE HealthCare, Philips, and Canon Medical, are offering energy-efficient, compact, and AI-enhanced imaging solutions. Cloud-based storage, remote reading, and AI-assisted analysis are increasingly used to optimize workflow and diagnostic accuracy.
Market Players Outlook
The major companies operating in the UK medical device technology market include Medtronic plc, Siemens Healthineers, GE Healthcare, Abbott Laboratories, and B. Braun Melsungen SE, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In June 2024, Royal Philips showcased the first mobile virtually helium-free MRI system, marking a significant step as an innovator to improve patient access to diagnostic technology whilst caring for the environment. This significantly reduces consumption of helium, which globally is in scarce supply. More than 1.9 million liters of helium have been saved by MR systems equipped with Philips’ BlueSeal magnet technology since 2018.
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the UK medical device technology market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
Table of Contents
111 Pages
- 1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- UK Medical Device Technology Market Sales Analysis – Device Type ($ Million)
- 1.1. Research Methodology
- Primary Research Approach
- Secondary Research Approach
- 1.2. Market Snapshot
- 2. Market Overview and Insights
- 2.1. Scope of the Study
- 2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key UK Medical Device Technology Industry Trends
- 2.2.2. Market Recommendations
- 3. Market Determinants
- 3.1. Market Drivers
- 3.1.1. Drivers For UK Medical Device Technology Market: Impact Analysis
- 3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For UK Medical Device Technology Market: Impact Analysis
- 3.3. Market Opportunities
- 3.3.1. Opportunities For UK Medical Device Technology Market: Impact Analysis
- 4. Competitive Landscape
- 4.1. Competitive Dashboard – UK Medical Device Technology Market Revenue and Share by Manufacturers
- Medical Device Technology Product Comparison Analysis
- 4.2. Key Company Analysis
- 4.2.1. Abbott Laboratories
- 4.2.1.1. Overview
- 4.2.1.2. Product Portfolio
- 4.2.1.3. Financial Analysis
- 4.2.1.4. SWOT Analysis
- 4.2.1.5. Business Strategy
- 4.2.2. B. Braun Melsungen
- 4.2.2.1. Overview
- 4.2.2.2. Product Portfolio
- 4.2.2.3. Financial Analysis
- 4.2.2.4. SWOT Analysis
- 4.2.2.5. Business Strategy
- 4.2.3. GE HealthCare
- 4.2.3.1. Overview
- 4.2.3.2. Product Portfolio
- 4.2.3.3. Financial Analysis
- 4.2.3.4. SWOT Analysis
- 4.2.3.5. Business Strategy
- 4.2.4. Medtronic plc
- 4.2.4.1. Overview
- 4.2.4.2. Product Portfolio
- 4.2.4.3. Financial Analysis
- 4.2.4.4. SWOT Analysis
- 4.2.4.5. Business Strategy
- 4.2.5. Siemens Healthineers
- 4.2.5.1. Overview
- 4.2.5.2. Product Portfolio
- 4.2.5.3. Financial Analysis
- 4.2.5.4. SWOT Analysis
- 4.2.5.5. Business Strategy
- 4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration
- 5. UK Medical Device Technology Market Sales Analysis by Device Type ($ Million)
- 5.1. In Vitro Diagnostics Devices
- 5.2. Diagnostic Imaging Devices
- 5.3. Cardiology Devices
- 5.4. Ophthalmology Devices
- 5.5. Orthopedic Devices
- 5.6. Others
- 6. Company Profiles
- 6.1. Abbott Laboratories
- 6.1.1. Quick Facts
- 6.1.2. Company Overview
- 6.1.3. Product Portfolio
- 6.1.4. Business Strategies
- 6.2. B. Braun Melsungen SE
- 6.2.1. Quick Facts
- 6.2.2. Company Overview
- 6.2.3. Product Portfolio
- 6.2.4. Business Strategies
- 6.3. Baxter International Inc.
- 6.3.1. Quick Facts
- 6.3.2. Company Overview
- 6.3.3. Product Portfolio
- 6.3.4. Business Strategies
- 6.4. Becton, Dickinson and Co. (BD)
- 6.4.1. Quick Facts
- 6.4.2. Company Overview
- 6.4.3. Product Portfolio
- 6.4.4. Business Strategies
- 6.5. Boston Scientific Corp.
- 6.5.1. Quick Facts
- 6.5.2. Company Overview
- 6.5.3. Product Portfolio
- 6.5.4. Business Strategies
- 6.6. Cardinal Health Inc.
- 6.6.1. Quick Facts
- 6.6.2. Company Overview
- 6.6.3. Product Portfolio
- 6.6.4. Business Strategies
- 6.7. Danaher Corp.
- 6.7.1. Quick Facts
- 6.7.2. Company Overview
- 6.7.3. Product Portfolio
- 6.7.4. Business Strategies
- 6.8. Edwards Lifesciences Corp.
- 6.8.1. Quick Facts
- 6.8.2. Company Overview
- 6.8.3. Product Portfolio
- 6.8.4. Business Strategies
- 6.9. Fresenius Medical Care AG & Co. KGaA
- 6.9.1. Quick Facts
- 6.9.2. Company Overview
- 6.9.3. Product Portfolio
- 6.9.4. Business Strategies
- 6.10. GE HealthCare
- 6.10.1. Quick Facts
- 6.10.2. Company Overview
- 6.10.3. Product Portfolio
- 6.10.4. Business Strategies
- 6.11. Intuitive Surgical Inc.
- 6.11.1. Quick Facts
- 6.11.2. Company Overview
- 6.11.3. Product Portfolio
- 6.11.4. Business Strategies
- 6.12. Koninklijke Philips N.V. (Philips)
- 6.12.1. Quick Facts
- 6.12.2. Company Overview
- 6.12.3. Product Portfolio
- 6.12.4. Business Strategies
- 6.13. Medline Industries LP
- 6.13.1. Quick Facts
- 6.13.2. Company Overview
- 6.13.3. Product Portfolio
- 6.13.4. Business Strategies
- 6.14. Medtronic plc
- 6.14.1. Quick Facts
- 6.14.2. Company Overview
- 6.14.3. Product Portfolio
- 6.14.4. Business Strategies
- 6.15. Mindray Medical International Ltd.
- 6.15.1. Quick Facts
- 6.15.2. Company Overview
- 6.15.3. Product Portfolio
- 6.15.4. Business Strategies
- 6.16. Olympus Corp.
- 6.16.1. Quick Facts
- 6.16.2. Company Overview
- 6.16.3. Product Portfolio
- 6.16.4. Business Strategies
- 6.17. ResMed Inc.
- 6.17.1. Quick Facts
- 6.17.2. Company Overview
- 6.17.3. Product Portfolio
- 6.17.4. Business Strategies
- 6.18. Siemens Healthineers
- 6.18.1. Quick Facts
- 6.18.2. Company Overview
- 6.18.3. Product Portfolio
- 6.18.4. Business Strategies
- 6.19. Smith & Nephew plc
- 6.19.1. Quick Facts
- 6.19.2. Company Overview
- 6.19.3. Product Portfolio
- 6.19.4. Business Strategies
- 6.20. Steris plc
- 6.20.1. Quick Facts
- 6.20.2. Company Overview
- 6.20.3. Product Portfolio
- 6.20.4. Business Strategies
- 6.21. Stryker Corp.
- 6.21.1. Quick Facts
- 6.21.2. Company Overview
- 6.21.3. Product Portfolio
- 6.21.4. Business Strategies
- 6.22. Terumo Corp.
- 6.22.1. Quick Facts
- 6.22.2. Company Overview
- 6.22.3. Product Portfolio
- 6.22.4. Business Strategies
- 6.23. Zimmer Biomet Holdings Inc.
- 6.23.1. Quick Facts
- 6.23.2. Company Overview
- 6.23.3. Product Portfolio
- 6.23.4. Business Strategies
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

